Reports of Patent, Design, and Trade Mark Cases, Issues 13-25Published at the Patent Office Sales Branch, 2007 - Industrial property |
From inside the book
Results 1-3 of 17
Page 488
... restenosis and stents . A brief passage stated that stents might be placed in arteries ( including coronary arteries ) and veins to prevent recurrent stenosis at an angioplasty site . Very extensive amendments to the claims had been ...
... restenosis and stents . A brief passage stated that stents might be placed in arteries ( including coronary arteries ) and veins to prevent recurrent stenosis at an angioplasty site . Very extensive amendments to the claims had been ...
Page 492
... restenosis . Restenosis occurs in 33 % to 50 % ( or possibly more ) of patients . It normally takes place within six months following the angioplasty procedure , and is likely to re - occur at the same sort of rate among patients who ...
... restenosis . Restenosis occurs in 33 % to 50 % ( or possibly more ) of patients . It normally takes place within six months following the angioplasty procedure , and is likely to re - occur at the same sort of rate among patients who ...
Page 499
... restenosis . He said : " [ 53 ] In summary , therefore , the problem of restenosis was a problem that had been identified in the early years of balloon angioplasty . Stenting had begun in about 1985 and the first reported instance of ...
... restenosis . He said : " [ 53 ] In summary , therefore , the problem of restenosis was a problem that had been identified in the early years of balloon angioplasty . Stenting had begun in about 1985 and the first reported instance of ...
Contents
EDITORS INTRODUCTION | v |
CASES REPORTED IN NUMERICAL ORDER | xiv |
CASES NOTED IN JUDGMENTS AND DECISIONS REPORTED | xxiv |
Copyright | |
1 other sections not shown
Other editions - View all
Common terms and phrases
added subject matter agreement Akzo Nobel Angiotech Pharmaceuticals Inc Appeal to Court application for revocation Appointed Person BACTIGUARD chiral citalopram claimants co-proprietor's application common general knowledge comparative advertising Comptroller consent Court of Appeal decision declarations of invalidity DESIGN AND TRADE divisional applications Dr Pinkava duties earlier mark earlier trade mark enantiomers European patents evidence grounds for refusal Halliburton Energy Services hearing officer Intellectual Property Office inventive step issue jurisdiction L'Oréal licence LIFFE likelihood of confusion Lundbeck Malynicz non-use opposition parallel trading particulars of infringement patentable subject matter Patents Act 1977 Patents Court perfumes pharmaceutical Playtech prior art racemate referred registered proprietor registered trade mark registrar relation relative grounds relevant REPORTS OF PATENT restenosis skilled person smell-alike specification stent Sweet & Maxwell taxol tibolone TRADE MARK 2007 Trade Mark Application trade marks declarations United Kingdom validating amendments VITALITE Vitasoy